News Releases

A New Strategy for Making Blood Stem Cells Healthier
Two Prominent Researchers Take Helm of Psychiatric Research Institute at Montefiore Einstein
Two Nature Papers Highlight an Understudied Protein

Facts & Stats

Published Papers
NIH Research Funding
Full-time Faculty
Global Initiatives
Clinical and Research Centers

Expert List for Media

William R. Jacobs Jr.

William R. Jacobs Jr., Ph.D.

Area(s) of expertise: Infectious diseasesTuberculosis (TB)Vaccines

Dr. Jacobs is pioneering the use of molecular genetics to control tuberculosis (TB), which kills nearly two million people a year. His research is identifying the genes that make Mycobacterium  tuberculosis (MTB) - the bacteria… Learn more

Einstein in the News

The Scientist
What's Ahead for SARS-CoV-2 Research in 2021

Kartik Chandran, Ph.D., talks about the future of COVID-19 research, including the development of treatments and vaccines to treat and prevent the novel coronavirus as it mutates over time. Dr. Chandran is professor of microbiology & immunology and the Harold and Muriel Block Scholar in Virology at Einstein.

More coverage on Dr. Chandran

The New York Times
Blood Plasma Reduces Risk of Severe Covid-19 if Given Early

Liise-anne Pirofski, M.D., discusses a small Argentinian clinical trial that found convalescent plasma was effective in reducing the risk of severe COVID-19 in older patients if they received the treatment within three days of showing symptoms. Dr. Pirofski is chief of infectious diseases at Einstein and Montefiore.

More coverage on Dr. Pirofski

The New York Times
Small Number of COVID Patients Develop Severe Psychotic Symptoms

Jonathan Alpert, M.D., Ph.D., and Vilma Gabbay, M.D., discuss their published case report on two patients who developed psychosis for the first time after recovering from COVID-19. Dr. Alpert is chair of psychiatry and behavioral sciences at Einstein and Montefiore and Dr. Gabbay is co-director of the Psychiatry Research Institute at Montefiore Einstein.


When a Drug Becomes a Child’s Last Hope

Einstein scientist Vern Schramm, Ph.D., never imagined that his basic research into enzymes would intersect with a 2-year-old girl dying from an incurable form of blood cancer. He and that girl (Katie Lambertson, now a teenager) and her parents share their stories.

Watch more videos

The Doctor's Tablet Blog